Severe Influenza Cohort

计划入组 227 人 · 首次发布于 2015 年 3 月 19 日

Severe Influenza Trial of ARbidol

计划入组 200 人 · 首次发布于 2018 年 12 月 26 日

Early Corticosteroids in Severe Influenza Pneumonia

计划入组 544 人 · 首次发布于 2026 年 8 月 26 日

FFAR4 activator program (severe asthma)

JAK inhibitors (inhaled, severe asthma)

trivalent influenza vaccine

Research Institute of Influenza

Russia

NATIONAL INSTITUTE OF DISEASES OF THE CHEST AND HOSPITAL

Bangladesh

Sernova Corp

Canada

Poolbeg Pharma Secures European Patent for POLB 001 Targeting Severe Influenza and Cancer Immunotherapy Side Effects

Largest Real-World Study Finds Early Oseltamivir Treatment Reduces ICU Admissions in Hospitalized Children with Influenza

FDA Advisory Panel Unanimously Backs Moderna's mRNA Flu Vaccine, Setting Stage for First mRNA Seasonal Flu Shot